Slingshot members are tracking this event:
The FDA has asked Teva to re-analyze blood levels of certain metabolites in a CRL for SD-809 NDA. Teva will submit its response in Q3
Slingshot Insights Explained
Oct 20, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Sd-809, Deutetrabenazine, Huntington's Disease